Josh's Shared Resources
Preventing Relapse and Hospitalization in Schizophrenia
The prevention of relapse and hospitalization in schizophrenia is a significant public health challenge. Antipsychotic medications reduce relapse risk, with...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Mindfulness-Based Interventions in Schizophrenia
A review of 22 randomized controlled trials involving 1500 patients with schizophrenia spectrum disorder explored the use of mindfulness-based interventions...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Emerging Treatments for Schizophrenia: Addressing Gaps in Symptom Management and Adherence Challenges
Schizophrenia is a severe condition treated primarily with dopamine-modulating antipsychotics, which mainly address positive symptoms but often fail to manage...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Predictors of Medication Response in Treatment-Resistant Schizophrenia
A study aimed to identify predictors of medication response in treatment-resistant schizophrenia (TRS) by analyzing baseline patient and study characteristics...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Study Identifies Unique Metabolites for Diagnosing Schizophrenia and Bipolar Disorder
Schizophrenia (SCZ) and bipolar disorder (BD) are severe mental disorders with overlapping symptoms such as delusions and hallucinations, posing diagnostic...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Transcranial Direct Current Stimulation: A Promising Treatment for Schizophrenia
Transcranial direct current stimulation (tDCS) is a promising treatment for schizophrenia, improving clinical symptoms, cognitive function, and neuroplasticity. Recent studies...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University